Trial intelligence / Profile preview

Fentanyl PCA for SAH Headache

NCT01851720Phase 3Terminated

Sponsor
Johns Hopkins University
Start
Jul 2012
Primary completion
Sep 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fentanyl in subarachnoid hemorrhage (SAH), sponsored by Johns Hopkins University. Started Jul 2012; status: terminated.

02

Drugs

fentanyl
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on NCT01851720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01851720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call